Unknown

Dataset Information

Cisplatin-associated ototoxicity amongst cervical cancer patients: A prospective cohort study in south Africa.


ABSTRACT:

Background

Concurrent chemoradiotherapy using weekly cisplatin remains standard of care for locally advanced cervical cancer in Sub-Saharan Africa. While cisplatin remains a popular cancer chemotherapeutic, it has an irreversible ototoxic effect on patients' auditory system. However, there is a paucity of epidemiological information on its extent and severity during cervical cancer treatment. In a region with a high burden of cervical cancer, this has serious consequences for aural intervention and rehabilitation.

Methods and findings

Using a prospective cohort study design, 82 patients with incident cervical cancer, receiving weekly cisplatin chemotherapy (50 mg/m2 body surface) at a tertiary level hospital in KwaZulu-Natal Province of South Africa, underwent audiological a

SUBMITTER: Paken J 

PROVIDER: S-EPMC10072443 | biostudies-literature | 2023

REPOSITORIES: biostudies-literature